SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001640334-20-002157
Filing Date
2020-08-17
Accepted
2020-08-14 18:37:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A nmus_sc13da.htm SC 13D/A 30285
  Complete submission text file 0001640334-20-002157.txt   32142
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Emerald Bioscience, Inc. (Subject) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87830 | Film No.: 201107235
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OFFICE 8262 THE LANDING, 200-375 WATER ST. VANCOUVER A1 V6B 0M9
Business Address OFFICE 8262 THE LANDING, 200-375 WATER ST. VANCOUVER A1 V6B 0M9 858-361-4499
Emerald Health Sciences Inc. (Filed by) CIK: 0001728413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A